(NASDAQ: AZTA) Azenta's forecast annual revenue growth rate of 3.5% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.13%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.66%.
Azenta's revenue in 2026 is $613,566,000.On average, 9 Wall Street analysts forecast AZTA's revenue for 2026 to be $27,479,690,677, with the lowest AZTA revenue forecast at $26,313,073,172, and the highest AZTA revenue forecast at $28,344,468,355. On average, 9 Wall Street analysts forecast AZTA's revenue for 2027 to be $28,676,535,974, with the lowest AZTA revenue forecast at $27,326,361,302, and the highest AZTA revenue forecast at $29,733,632,497.
In 2028, AZTA is forecast to generate $30,230,419,674 in revenue, with the lowest revenue forecast at $28,811,903,908 and the highest revenue forecast at $31,601,184,291.